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The concept of ‘patient experience’ has become central to how to improve healthcare.
Remote communication with patients is today a frequent practice in healthcare services,
showing similar outcomes to standard outpatient care while enabling cost reduction in both
formal and informal care. The purpose of this study was to analyse the experiences of peo-
ple with telemonitoring pacemakers.
Methods
Patients were randomly allocated to either the telemonitoring or hospital monitoring follow-
ups. Using the ‘Generic Short Patient Experiences Questionnaire’ (GS-PEQ), as well as an
ad-hoc survey from the ‘telehealth patient satisfaction survey’ and ‘costs survey’, patients’
experiences were measured six months after the pacemaker implant in a cohort of 50 con-
secutive patients. The mean age was 74.8 (± 11.75) years and 26 (52%) patients were male
of which 1 was lost in follow-up. Finally, 24 patients were followed up with standard hospital
monitoring, while 25 used the telemonitoring system. Differences in baseline characteristics
between groups were not found.
Results
Findings showed overall positive and similar experiences in patients living with telemonitor-
ing and hospital monitoring pacemakers. Significant differences were found in GS-PEQ con-
cerning how telemonitoring patients received less information about their diagnosis/
afflictions (p = 0.046). We did not find significant differences in other items such as ‘confi-
dence in the clinicians’ professional skills’, ‘treatment perception adapted to their situation’,
‘involvement in decisions regarding the treatment’, ‘perception of hospital organisation’,
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‘waiting before admission’, ‘satisfaction of help and treatment received’, ‘benefit received’,
and ‘incorrect treatment’.
Conclusions
The remote communication of pacemakers was met with positive levels of patients’ experi-
ences similarly to patients in the hospital monitoring follow-up. However, telemonitoring
patients received less information. Thus, improving the quality and timing of information is
required in telemonitoring patients in the planning and organisation of future remote commu-
nication healthcare services for people living with a pacemaker implant.
1. Introduction
Cardiovascular diseases are one of the most frequent reasons of disease-associated mortality
[1]. In Norway, cardiovascular diseases are one of the main cause-of-death disease groups,
with myocardial infarction being one of the five most important specific causes of death [2].
Worldwide around 3 million people have a pacemaker and around 600,000 pacemakers are
implanted every year [3]. According to clinical guidelines, patients with an implanted PM
need to be followed-up every 3–12 months [4, 5]. Every consultation frequently involves an
assessment of the device’s function, cardiac events, and the patient’s clinical status and, if
needed, the pacemaker is reprogrammed or pharmacotherapy is changed [4, 6]. In our current
ageing population, there are increasing indications with respect to persons carrying an
implant. The follow-up is today a substantial load for national health services [7] as well as for
patients and their relatives [8, 9]. In fact, it has been shown that people with cardiovascular
conditions demand a large amount of follow-ups and hospital admissions in Norway [10]. In
this regard, remote communication in cardiology could mitigate the increasing workload of
follow-ups of pacemakers [11].
In the last Norwegian Coordination Reform in the healthcare sector [12], remote commu-
nication and the use of telehealth strategies were emphasised. Remote communication
between healthcare providers and patients is considered today a tool that decreases outpatient
consultations and costs [13]. In fact, long-distance communication with implanted devices is
now a reality. Recent studies have shown that using telemonitoring in patients with pacemak-
ers can result in similar clinical outcomes to standard outpatient care while allowing more flex-
ible services organisation and greater cost reduction in both formal and informal care [9, 14,
15]. Moreover, remote monitoring (RM) or telemonitoring (TM) systems have potential
advantages such as early detection of cardiovascular events and early response to technical
problems in the device or alterations in the patient’s clinical condition [16, 17]. TM could rep-
resent a possible solution in helping to reduce the number of consultations and travels to hos-
pital, thereby optimising healthcare resources [15].
Pacemakers are devices that help to monitor abnormal heart rhythms and regulate heart-
beats being placed in the chest [1,18]. A pacemaker implant is a very important life event, so
these patients may have different and particular experiences of living with such a device [1]. In
this regard, it is important to analyse their experiences in order to develop high-quality health-
care services [19]. Indeed, the experience of patients is more and more being considered clini-
cally important and the concept of ‘patient experience’ has become relevant and central when
it comes to increase the quality of healthcare services [20]. In telehealth, both the technology
Experiences of remote communication in pacemakers
PLOS ONE | https://doi.org/10.1371/journal.pone.0218521 June 20, 2019 2 / 13
Competing interests: The authors have declared
that no competing interests exist.
and users’ experiences are key determinants of the acceptance and accomplishment of these
implementations [21].
Although many economic evaluations and outcome studies have been conducted, few have
inquired as to how individuals experience living with remote monitoring pacemakers. We
found one study analysing patients’ experiences with standard on-clinic monitored pacemak-
ers [22]. A previous literature review [23] found three studies comparing the experiences of
people with pacemakers and implantable cardiac defibrillators (ICD) [24–26]. In the field of
telemonitoring cardiac devices, one study analysed diverse aspects of remote monitored ICDs,
such as ease of use of the system, acceptance, and satisfaction of patients and clinicians [21]. A
recent study [20] enrolled 14 patients with an insertable cardiac monitor (ICM) so as to
explore patients’ experiences, and claimed the need for studies on other cardiac telemonitoring
technologies. We have not found previous studies specifically on patients’ experiences with
remote monitoring pacemakers. Therefore, the aim of this study was to explore the experiences
of people living with telemonitoring pacemakers. The rationale was to produce pertinent and
translatable knowledge for future opportunities in healthcare contexts of these patients and to
direct future research.
2. Materials and methods
This paper is part of a larger project in Norway, the NORDLAND study (2014–2017), wherein
a team has collaborated which includes chronic heart patients with a pacemaker, their relatives,
cardiologists, nurses, psychologists, and health communication experts. This study is based on
a randomised, non-masked observational design where participants were assigned to either
follow-up consultations in the hospital or follow-up by remote communication technologies.
Participants were recruited in Nordland Hospital, Bodø, Norway. This hospital with a pace-
maker centre covers 170,000 inhabitants and conducts around 80–90 pacemaker implants per
year [27].
The following protocol has been described in detail previously [27]. Every patient who was
scheduled for a pacemaker implant between August 2014 and October 2015 and met all of the
inclusion criteria: aged 18 years or older, capacity to provide informed consent and to
manoeuvre the home monitor system, and life expectancy >1 year, as well as none of the
exclusion criteria: scheduled for an implantable cardioverter-defibrillator (ICD) or cardiac
resynchronisation therapy (CRT) and involvement in other studies at the same time, was
invited to participate. A total of 76 patients were screened and 50 patients were included and
randomised to either telemonitoring (TM, n = 25) or hospital monitoring (HM, n = 25), before
being implanted with the pacemaker. The randomisation process was performed as follows: a
person unrelated to the study prepared a total of 50 sealed envelopes, 25 of which included a
note reading "tele-monitoring" and 25 a note reading "hospital monitoring". The envelopes
were thoroughly mixed and numbered from 1 to 50. When a patient accepted the invitation to
participate in the trial and signed the informed consent he or she received a consecutive num-
ber and was allocated to follow-up in accordance with the specification included in the corre-
sponding envelope. Thus, the investigators had no knowledge of or influence on the
randomisation result prior to inclusion.
Depending on their diagnosis, patients were implanted with either a single (VVIR) or a
dual chamber (DDDR) pacemaker. For further characteristics and descriptions of the devices
that were received by each group of participants please see the previously published article
[27].
Data collection was performed 6 months after surgery, by a phone call from one of the
research team members. In total, 24 HM patients and 25 TM patients participated, with each
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participant answering 20 questions. To assess the experiences of the users with PM, an ad-hoc
questionnaire was created by merging validated questionnaires assessing users’ experiences.
The items included comprised the full version of the Generic Short Patient Experiences Ques-
tionnaire (GS-PEQ), adding some questions from the telehealth patient satisfaction survey and
a costs survey. The Generic Short Patient Experiences Questionnaire (GS-PEQ) is a short set
of questions on user experiences with specialist healthcare that covers certain relevant topics.
It was created and has been validated in Norway [28]. The questionnaire includes 10 questions
(see questions 1–10 in the S1 File) about the following topics: outcome (2), clinician services
(2), user involvement (2), incorrect treatment (1), information (1), organisation (1), and acces-
sibility (1). Additionally, to evaluate other aspects of the telehealth experience by patients who
have been implanted with home-monitored pacemakers, we used an adapted version of the tel-
ehealth patient satisfaction survey [29] and the costs survey [30]. These surveys are composed
of closed- and open-ended questions exploring the patients’ experiences with the home moni-
toring technology, as well as some specific data on costs that they might have with regard to
the pacemaker monitoring (see questions 11–20 in the S1 File).
The protocol was approved by the Regional Ethics Committee–REK Nord (Tromsø, Nor-
way), with the committee´s reference number being as follows: 2014/383/REK Nord. The
study was developed in accordance with the precepts of the Declaration of Helsinki. All
patients signed the corresponding informed consent prior to their enrolment and appropriate
measures were taken to ensure data privacy.
With regard to statistical analyses, following a similar approach of a previous study [9], first
patient baseline characteristics and potential differences between groups were compared using
a difference in means test for continuous variables and a difference in proportions test (bino-
mial method) or chi-square test (replaced by the Fisher exact test for cells with n<5 cases) for
qualitative variables. Secondly, results from the questionnaire were presented on a single ques-
tion basis with comparison between the two groups, telemonitoring and hospital monitoring,
using the Mann–Whitney U test for ordinal data and the chi-square test for nominal data.
Analyses were carried out with SPSS 24th edition (SPSS Institute, Inc., Chicago, IL, USA) sta-
tistical software. Fig 1 shows the flow (CONSORT) diagram of the study. This figure has been
previously published [27].
3. Results
Baseline characteristics are presented in Table 1. This table has been previously published [27].
There were no major differences between the telemonitoring and the hospital monitoring
groups with regard to age, gender, pacing indication, and other clinical characteristics. Differ-
ences were only found in those items that are directly influenced by the type of monitoring:
‘transmissions from patient’s home’ and ‘calls/letters sent to the patients’.
In relation to the results derived from the questionnaire, overall experience with both types
of follow-ups was positive and, as presented in Table 2, there were few differences between the
home monitoring and the hospital monitoring groups with respect to the individual questions.
Using the Mann–Whitney U test, χ2 test and Fisher exact test, we only found significant p val-
ues in two questions (Q3 and Q12). Q3 asked whether patients obtained sufficient information
about their diagnosis/afflictions, and Q12 asked for the time that it takes patients to attend a
cardiology consultation. In general, responses showed positive experiences, and although these
were also positive, the lowest scoring was for Q4 and Q6, for both the intervention and control
group patients. These questions concern treatment and organisational perceptions by patients
(see Table 3 and full data set in the S1 File).
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4. Discussion
The NORDLAND study explored the patients’ experiences with living with telemonitoring
pacemakers. To the best of our knowledge, this is the first study to explore patients’ experi-
ences in respect of living with telemonitoring pacemakers. The findings revealed: i) overall
positive experiences in patients living with telemonitoring pacemakers; ii) significant differ-
ences in the GS-PEQ between both groups concerning telemonitoring patients receiving less
information about their diagnosis/afflictions than those ones in hospital monitoring; iii) signif-
icant differences in how TM patients take more time to attend a cardiology consultation at
hospital than HM patients; and iv) that no significant differences between groups were found
in the rest of the items, such as ‘confidence in the clinicians’ professional skills’, ‘treatment per-
ception adapted to their situation’, ‘involvement in decisions regarding the treatment’, ‘percep-
tion of hospital organisation’, ‘waiting before admission’, ‘satisfaction of help and treatment
received’, ‘benefit received’, and ‘incorrect treatment’.
The overall positive experience found in our study is confirmed and well aligned with previ-
ous studies analysing experiences of telehealth devices. In a previous study evaluating tele-
health in primary care [31], patients found that this new remote communication with
healthcare providers was a flexible, convenient, easy-to-use and acceptable means of their
jointly managing their condition with a responsible health professional. Another study [21]
Fig 1. Flow (CONSORT) diagram of the study.
https://doi.org/10.1371/journal.pone.0218521.g001
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found that the ease of use, satisfaction, and acceptance of remote monitoring of implantable
defibrillators appeared to be elevated both for patients and for clinicians. However, in spite of
these positive results, we need to be cautious, since the implementation of telehealth in regular
healthcare practice is difficult [21]. Indeed, 15–20 years ago, it was reported that most tele-
health initiatives had become a failure in daily practice, since poor technical feasibility often
results in distrust from users and low levels of satisfaction [32, 33]. Nowadays, we can see that
technical problems are very much minimised; thus, users’ experiences are more positive, as
our findings have revealed.
Table 1. Selected patient baseline characteristics by intervention status.
All (n = 50) Groups P-value
Telemonitoring Hospital monitoring
Age 74.84 (± 11.75) 73.68 (± 14.22) 76.00 (± 8.77) 0.676
Men 26 (52.0) 13 (52.0) 13 (52.0) 1.00
Pacing indication N (%)
Sick sinus syndrome 24 (48.0) 12 (48.0) 12 (48.0) 0.648
Atrioventricular block 20 (40.0) 11 (44.0) 9 (36.0)
Chronic AF with bradycardia 6 (12.0) 2 (8.0) 4 (16.0)
Disease manifestations N (%)
Syncope 14 (28.0) 8 (32.0) 6 (24.0) 0.812
Dizziness 25 (50.0) 12 (48.0) 13 (52.0)
Dyspnoea 11 (22.0) 5 (20.0) 6 (24.0)
Service derived N (%)
Emergency dept. 3 (6.0) 1 (4.0) 2 (8.0) 0.505
Cardiology ward 14 (28.0) 5 (20.0) 9 (36.0)
Primary healthcare 4 (8.0) 2 (8.0) 2 (8.0)
Other hospitals 29 (58.0) 17 (68.0) 12 (48.0)
Stimulation N (%)
DDDR 44 (88.0) 23 (92.0) 21 (84.0) 0.334
VVIR 6 (12.0) 2 (8.0) 4 (16.0)
Comorbidities N (%)
Dislipidemia 27 (54.0) 13 (52.0) 14 (56.0) 0.500
Obesity (BMI >30) 1 (2.0) 0 (0.0) 1 (4.0) 0.500
Tachyarrhythmia 18 (36.0) 7 (28.0) 11 (44.0) 0.189
Hypertension 32 (64.0) 17 (68.0) 15 (60.0) 0.384
Other comorbidities N (%)
None 18 (36.0) 11 (44.0) 7 (28.0) 0.388
Others 10 (20.0) 6 (24.0) 4 (16.0)
Coronary heart diseases 22 (44.0) 8 (32.0) 14 (56.0)
Pharmaceutical treatment N (%)
Antiaggregants 18 (36.0) 8 (32.0) 10 (40.0) 0.384
Anticoagulants 25 (50.0) 10 (40.0) 15 (60.0) 0.129
Antiarrhythmics 18 (36.0) 7 (28.0) 11 (44.0) 0.189
Antihypertensives 32 (64.0) 18 (72.0) 14 (56.0) 0.189
n = 50 (Telemonitoring group: 25; Hospital monitoring group: 25). Values are expressed as means or proportions. SD: Standard deviation; 95 CI: 95% confidence
interval of means; DDDR: Bicameral pacemaker with two electrodes placed in the atrium and in the ventricle; VVIR: Unicameral pacemaker with an electrode in the
ventricle with the ability to modulate frequency of stimulation; BMI: Body mass index. Note: this table has been previously published in a previous article [27].
https://doi.org/10.1371/journal.pone.0218521.t001
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Table 2. Follow-up information at 6 months.
All (n = 49) Groups P-value
Telemonitoring Hospital monitoring
Number of transmissions from hospital N (%)
0 0 (0.0) 0 (0.0) 0 (0.0) 0.26
1 41 (83.7) 21 (84.0) 20 (83.3)
2 6 (12.2) 2 (8.0) 4 (16.7)
3 2 (4.1) 2 (8.0) 0 (0.0)
Number of transmissions from patient’s home N (%)
0 29 (59.2) 5 (20.0) 24 (100) <0.001
3–5 15 (30.6) 15 (60.0) 0 (0.0)
6–8 5 (10.2) 5 (20.0) 0 (0.0)
Extra transmissions from patient’s home N (%)
0 45 (91.8) 21 (84.0) 24 (100) 0.12
1 1 (2.0) 1 (4.0) 0 (0.0)
3 3 (6.2) 3 (12.0) 0 (0.0)
Cardiovascular events N (%)
None 46 (93.9) 23 (92.0) 23 (95.8) 0.40
PCI 1 (2.0) 1 (4.0) 0 (0.0)
Angina 1 (2.0) 0 (0.0) 1 (4.2)
Lead dislodgement x 2 1 (2.0) 1 (2.0) 0 (0.0)
Calls/letters sent to the patients N (%)
0 27 (55.1) 4 (16.0) 23 (95.8) <0.001
1 21 (42.9) 20 (80.0) 1 (4.2)
3 1 (2.0) 1 (4.0) 0 (0.0)
Changes of medication N (%)
0 33 (67.3) 17 (68.0) 16 (66.7) 0.11
1 7 (14.3) 5 (20.0) 2 (8.3)
2 3 (6.1) 1 (4.0) 2 (8.3)
3 4 (8.2) 0 (0.0) 4 (16.7)
4 2 (4.1) 2 (8.0) 0 (0.0)
Changes of pacemaker’s reprogramming N (%)
0 34 (69.4) 16 (64.0) 18 (75.0) 0.34
1 13 (26.5) 7 (28.0) 6 (25.0)
2 2 (4.1) 2 (8.0) 0 (0.0)
Number of hospitalisations (related or not to pacemaker’s implant) N (%)
0 30 (61.2) 14 (56.0) 16 (66.7) 0.55
1 14 (28.6) 7 (28.0) 7 (29.2)
2 4 (8.2) 3 (12.0) 1 (4.2)
5 1 (2.0) 1 (2.0) 0 (0.0)
Number of hospitalisation days (related or not to pacemaker’s implant) N (%)
0 30 (61.2) 14 (56.0) 16 (66.7) 0.54
1–5 12 (24.5) 6 (24.0) 6 (25.1)
6–10 4 (8.1) 2 (8.0) 2 (8.4)
+10 3 (6.0) 3 (12.0) 0 (0.0)
Reasons for hospitalisation N (%)
(Continued)
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Besides the overall positive experiences, one relevant outcome found in our study was that
telemonitoring patients received less information about their diagnosis/afflictions than those
ones in hospital monitoring. This is an important finding concerning the expectations of the
information that are normally provided by conversations with the health professionals and the
delivery of pamphlets. We believe that due to the reduction of face-to-face consultations, these
TM patients had a lesser chance of posing questions or clarifying issues in relation to their
diagnosis with the health professionals. Being well informed is a key ingredient in patients’
subjective experiences [34]. A recent study [20] also found that a characteristic part of the diag-
nostic process in ICM remote monitoring is that patients experience the feeling of ‘not know-
ing’ or ‘being uninformed’. According to the authors, this might be a result of “no news is
good news” in the home monitoring environment. The monitoring systems only inform the
health professionals when something goes wrong. According to the authors, this collides with
the needs of patients. Frequent contact with clinicians is needed so as to receive information
on the health status, especially for patients who are asymptomatic (as this contact is the only
way in which to know about their progress). Other previous studies [24, 25] carried out on
patients with hospital monitoring cardiac implants also support the recommendations of pro-
viding more information such as preceding to implantation. Among the patients, these studies
found more fear of death, of device malfunction, greater concerns about not being able to
work, and more worry with regard to having sex and driving. These studies recommend that
as these patients are mentally ill from depression or anxiety, they suggest that health profes-
sionals should be aware of significant symptoms, meeting the patients’ needs. Although we did
not find similar studies on telemonitoring patients with pacemakers, we believe that these
patients might have higher information needs than hospital monitoring, since their face-to-
face or phone contact with healthcare professionals is lower and, therefore, they might have
fewer opportunities to obtain information. This may lead us to an Albert Einstein quote: “It
has become appallingly obvious that our technology has exceeded our humanity.” In this
regard, we agree with Boriani et al. [11] in suggesting that the evolving capabilities of
implanted devices to monitor patients’ cardiac status (heart rhythm, fluid overload, right ven-
tricular pressure, oximetry, etc.) may imply a shift from strictly device-centred follow-up to
perspectives centred on the patient (and patient–device interactions). A patient-centred
approach could provide improvements in healthcare delivery and clinical outcomes in telemo-
nitoring patients.
Finally, we should mention that we found another difference between groups in Q12,
which asked for the time that it takes patients to attend a cardiology consultation. However,
we believe that this significant difference was a result of chance in spite of the p-value, as all
Table 2. (Continued)
All (n = 49) Groups P-value
Telemonitoring Hospital monitoring
None 30 (61.2) 14 (56.0) 16 (66.7) 0.37
Others 6 (12.3) 3 (12.0) 3 (12.5)
Cancer 1 (2.0) 1 (4.0) 0 (0.0)
Coronary problems 9 (18.4) 4 (16.0) 5 (20.8)
Pacemaker dysfunction 3 (6.1) 3 (12.0) 0 (0.0)
n = 50 (Telemonitoring group: 25; Hospital monitoring group: 24). Values are expressed as means or proportions. SD: Standard deviation; 95 CI: 95% confidence
interval of means; PCI: Percutaneous coronary intervention. Note: this table has been previously published in a previous article [27].
https://doi.org/10.1371/journal.pone.0218521.t002
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Table 3. Results derived from the Generic Short Patient Experiences Questionnaire (GS-PEQ).







Question 1† 1 = Not at all; 2 = To a small extent; 3 = To a moderate extent; 4 = To a large extent; 5 = To
a very large extent
4 (1, 5) 5 (2, 5) 0.214
Question 2† 5 (4, 5) 5 (3, 5) 0.326
Question 3† 4 (2, 5) 5 (1, 5) �0.046
Question 4† 4 (3, 5) 5 (3, 5) 0.241
Question 5† 3 (1, 5) 3 (1, 5) 0.091
Question 6† 4 (3, 5) 4 (3, 5) 0.712
Question 7† 5 (3, 5) 5 (3, 5) 0.362
Question 8† 1 (1, 3) 1 (1, 2) 0.613
Question 9† 1 (1, 2) 1 (1, 5) 0.492
Question
10†
4 (1, 5) 5 (3, 5) 0.404
Question
11†
Number of kilometres 65 (1, 500) 40 (1, 300) .183
Question
12†
1 = <1 hour; 2 = 1–2 hours; 3 = 2–3 hours; 4 = 3–4 hours; 5 = >4 hours >4 (<1, >4) 2–3 (<1, >4) �.041
Question
13‡
1 = Public transport 8 (34.8) 3 (13.0) .323
2 = Own car 0 1 (4.3)
3 = Ambulance 10 (43.5) 10 (43.5)
4 = Taxi 1 (4.3) 3 (13.0)
5 = Other 4 (17.4) 6 (26.0)
Question
14‡
1 = Working 1 (4.3) 2 (8.7) .229
2 = Unemployed 0 0
3 = Pensionist 12 (52.2) 8 (34.8)
4 = Sick leave 8 (34.8) 13 (56.5)
5 = Other 2 (8.7) 0
Question
15‡
Yes 3 (13.0) 6 (26.1) .265
No 20 (87.0) 17 (73.9)
Question
16‡
1 = Working 2 (50.0) 4 (57.1) .368
2 = Unemployed 0 0
3 = Pensioner 1 (25.0) 3 (42.9)
4 = Sick leave 1 (25.0) 0
5 = Other 0 0
Question
17‡
Yes 17 (73.9) 15 (65.2) .522
No 6 (26.1) 8 (34.8)
Question
18†
36.55 (0–33.25) 22.10 (0–110.75) .611
Question
19‡
1 = None 19 (82.6) 22 (95.6) .200
2 = Once 3 (13.0) 0
3 = Twice 0 0
4 = More than 2 1 (4.4) 1 (4.4)
Question
20‡
1 = None 20 (87.0) 22 (95.6) .351
2 = Once 2 (8.7) 0
3 = Twice 0 0
4 = More than 2 1 (4.3) 1 (4.4)
�For questions 1–10, the following scoring was used: 1, not at all; 2, to a small extent; 3, to some extent; 4, to a large extent; and 5, to a very large extent.
†Data presented as median (min., max.).
‡Data presented as total number (percentage).
https://doi.org/10.1371/journal.pone.0218521.t003
Experiences of remote communication in pacemakers
PLOS ONE | https://doi.org/10.1371/journal.pone.0218521 June 20, 2019 9 / 13
participants were randomly allocated to one of both groups, either telemonitoring or hospital
monitoring follow-up.
Despite the relevant results obtained, the study has certain limitations. Firstly, some issues
in relation to measuring patient experience include the feedback biases by answering inten-
tionally to the questionnaires in order to accomplish positive outcomes. Some patients are also
confused because they consider the questions to be on their experience of their health condi-
tion [35]. Secondly, this is an open study wherein clinicians, researchers and patients knew the
follow-up category for all participants. Nevertheless, we believe that our study presents some
important strong points since the NORDLAND study is a randomised study in a field where it
is not frequent to conduct such method design. This ensures a major evidence level, a lesser
chance of bias due to random selection of the groups, and it might be repeatable and compara-
ble with other studies [27].
5. Conclusions
Our results showed that patients living with telemonitoring pacemakers have overall positive
experiences, similar to those with hospital monitoring pacemakers. Areas for improvement
should focus on improving the quality and timing of information during the entire therapeutic
process. To the best of our knowledge, this is the first publication to show patients’ experiences
of living with telemonitoring pacemakers.
Our study also includes some important practical implications. We believe that by achiev-
ing a better understanding of the experiential dimensions of these patients we can inform com-
munication practices between healthcare professionals and patients in the follow-up process of
a pacemaker implant. In fact, such little research into patient experiences of living with telemo-
nitoring pacemakers could also be a result of the poor educational preparation of health pro-
fessionals responsible for these patients. Therefore, our findings will support the development
of this important research field [36, 37]. Further organisation and management of healthcare
services should ensure the delivery of quality and timely information to patients during the
entire process, from pre-implantation to the follow-up phases.
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